The litigation centers on claims that Endava issued false and misleading statements regarding its fiscal health. The company was forced to delay its Q4 and full-year 2026 financial results after discovering a need for additional reviews of its customer and supplier agreements. This discrepancy in corporate reporting serves as the foundation for the complaint, which accuses the firm of breaching Rule 10b-5.
Shareholders holding DAVA stock during the specified window have until November 30, 2026, to act. While the DJS Law Group is soliciting potential lead plaintiffs to spearhead the case, the firm notes that such an appointment is not a prerequisite for individual investors to participate in a potential recovery. Interested parties may contact David J. Schwartz at the firm’s Eastchester, New York office to discuss their legal standing.

Comments (0)
No comments yet. Be the first!